Sort
64,565 grants matching “drug discovery”
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
$798,057Bryan E. Welm · University Of Utah · U01 · FY2019 · CA
Development of a Bioengineered Heparin from a Non-Animal Source
$797,935Robert J Linhardt · Rensselaer Polytechnic Institute · R01 · FY2009 · HL
Engineering Multifunctional Nanoparticles
$797,711Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2010 · CA
Collaborative Research: Frameworks: Scalable Performance and Accuracy analysis for Distributed and Extreme-scale systems (SPADE)
$797,666Shirley V Moore · University Of Texas At El Paso · · FY2023 · CSE
OSU K12 Training Grant in Oncology
$797,380William E. Carson · Ohio State University · K12 · FY2021 · CA
SPORE in Prostate Cancer
$797,371Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Mayo Clinic Breast Cancer SPORE
$797,371Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2021 · CA
Target based discovery of next generation pyrazinamide
$797,081Veronique Dartois · Hackensack University Medical Center · R01 · FY2020 · AI
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
$797,049Ram Samudrala · University Of Washington · DP1 · FY2013 · LM
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$796,986Nashaat Turkman · State University New York Stony Brook · R01 · FY2021 · AG
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$796,986Nashaat Turkman · State University New York Stony Brook · R01 · FY2022 · AG
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$796,986Nashaat Turkman · State University New York Stony Brook · R01 · FY2020 · AG
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics
$796,966Ann Marie Schmidt · New York University School Of Medicine · R24 · FY2015 · DK
Human Genetic determinants of HBV recovery
$796,842David L Thomas · Johns Hopkins University · R01 · FY2022 · AI
Wisconsin Stem Cell Research Center
$796,841Wicell Research Institute · P20 · FY2003 · GM
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
$796,786Scott Scarneo · Eydis Bio, Inc. · R44 · FY2021 · AR
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
$796,693Primo N Lara · University Of California At Davis · K12 · FY2020 · CA
Precision Phenomics to Personalize Drug Therapy (P3DT)
$796,664Joshua C. Denny · Vanderbilt University · P50 · FY2015 · GM
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
$796,538Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
$796,538Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · U01 · FY2021 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
$796,538Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · U01 · FY2023 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
$796,538Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · AG
Dissecting splicing factor mutations in iPSCs
$796,490Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Single-cell based diagnostic platform with single-molecular transcriptional response profiling for rapid phenotypic antimicrobial susceptibility testing of gonorrhea
$796,454Tza-Huei Jeff Wang · Johns Hopkins University · R01 · FY2024 · AI
MANIPULATING IKS AS A THERAPEUTIC APPROACH TO CARDIAC ARRHYTHMIAS
$796,414Jianmin Cui · Washington University · R01 · FY2015 · HL